Skip to main content

Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer

The Original Article was published on 26 January 2017

Correction: J Exp Clin Cancer Res 36, 19 (2017)

https://doi.org/10.1186/s13046-016-0487-8

Following the publication of the original article [1], author identified an error in Figure 4, specifically:

  • Figure 4d – migration distance of DOX treated 24h was pasted by using DOX treated 0h

The correct figure is given below.

Fig. 4
figure 1

RES synergized DOX effect on cell proliferation, colony formation and apoptosis and resvered DOX-induced cell migration in SGC7901/ DOX cells. a CCK8 was used to detect the cytotoxicity of DOX, RES or both. SGC7901/DOX cells were left untreated or treated with 0.75 mg/L DOX, 50 mg/L RES or both for 7 days. Each data point represents a mean value of four experiments and the error bars indicate the standard deviation (T test, vs. DOX + RES, *, p < 0.01; **, p < 0.001, n = 4). b Representative pictures of Colony-forming assay and number of cell colonies. After 48 h’ exposure to DOX or RES or both, the colony forming abilitiy of SGC7901/DOX cells was tested. (n = 3, *** p < 0.001; *, p < 0.05). c SGC7901/ DOX cells were treated with 1 mg/L DOX, 1.5 mg/L DOX, 50 mg/L RES, 100 mg/L RES or 0.75 mg/L DOX combined with 50 mg/L RES respectively for 48 h. Annexin V-FITC/PI dual staining apoptosis analysis was performed. The proportions of cells in each quadrant are marked on the figures. d The migration distance was meaured to analysed the migration ability of SGC7901/DOX cells which were left untreated or treated with 1 mg/L DOX, 50 mg/L RES or both for 48 h. The Scale bar represents 100 μm. The migration distance of each group was measured, with 162.89 ± 11.20 μm, 205.11 ± 6.79 μm, 76.34 ± 6.16 μm, 24.36 ± 4.83 μm for control, DOX, RES and DOX + RES group. (n = 4, *** p < 0.001;**p < 0.01). e SGC7901/ DOX cells were left untreated or treated with 1 mg/L DOX, 50 mg/L RES or 1 mg/L DOX simultaneously combined with 50 mg/l RES for 48 h. Then cells were subjected to transwell migration assay. The Scale bar represents 100 μm. The numbers of cells of the control, DOX, RES and DOX + RES groups were 700.40 ± 50.03, 922.00 ± 53.25, 271.60 ± 20.07 and 116.00 ± 6.50 respectively (n = 4, *** p < 0.001;**p < 0.01)

Reference

  1. Xu J, Liu D, Niu H, et al. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. J Exp Clin Cancer Res. 2017;36:19. https://doi.org/10.1186/s13046-016-0487-8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qingling Zhang.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, J., Liu, D., Niu, H. et al. Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer. J Exp Clin Cancer Res 42, 23 (2023). https://doi.org/10.1186/s13046-023-02593-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-023-02593-5